Cargando…

Serum omentin-1 level in patients with benign prostatic hyperplasia

BACKGROUD: To evaluate the relationship between omentin-1 and benign prostatic hyperplasia (BPH). BPH is the most common urological disease in elderly men worldwide. Lower serum omentin-1 levels were reported to be negatively associated with the incidence of inflammation, diabetes, obesity and metab...

Descripción completa

Detalles Bibliográficos
Autores principales:	He, Haiqing, Wu, Shuiqing, Hao, Jun, Wang, Long, Ai, Kai, Zhu, Xuan, Xu, Ran, Zhao, Xiaokun, Wang, Yinhuai, Zhong, Zhaohui
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2020
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7203873/ https://www.ncbi.nlm.nih.gov/pubmed/32375790 http://dx.doi.org/10.1186/s12894-020-00623-4

Ejemplares similares

Association between benign prostate hyperplasia and metabolic syndrome in men under 60 years old: a meta-analysis
por: Wu, Shuiqing, et al.
Publicado: (2019)

The long noncoding RNA LINC01140/miR-140-5p/FGF9 axis modulates bladder cancer cell aggressiveness and macrophage M2 polarization
por: Wu, Shuiqing, et al.
Publicado: (2020)

Benign Prostatic Hyperplasia
Publicado: (2015)

Serum Omentin Levels in Patients with Prostate Cancer and Associations with Sex Steroids and Metabolic Syndrome
por: Borowski, Artur, et al.
Publicado: (2020)

Association of the Serum Vascular Endothelial Growth Factor Levels With Benign Prostate Hyperplasia and Prostate Malignancies
por: Sharif, Mohammad Reza, et al.
Publicado: (2014)

Serum Levels of Matrix Metalloproteinase-1 in Brazilian Patients with Benign Prostatic Hyperplasia or Prostate Cancer
por: El-Chaer, William Khalil, et al.
Publicado: (2020)

Serum Omentin-1 in Psoriasis
por: Bakry, Ola Ahmed, et al.
Publicado: (2018)

Altered circulating levels of adipokine omentin-1 in patients with prostate cancer
por: Zhou, Lin, et al.
Publicado: (2019)

Testosterone and benign prostatic hyperplasia
por: Jarvis, Thomas R, et al.
Publicado: (2015)

Seminal vesicle abnormalities following prostatic artery embolization for the treatment of benign prostatic hyperplasia
por: Zhang, Jin Long, et al.
Publicado: (2018)

Changes of serum omentin-1 levels and relationship between omentin-1 and insulin resistance in chronic hepatitis C patients
por: Nassif, Walaa Moustafa Hussein, et al.
Publicado: (2013)

Areca Nut Chewing and an Impaired Estimated Glomerular Filtration Rate as Significant Risk Factors for Non-Muscle-Invasive Bladder Cancer Recurrence
por: Cao, Jian, et al.
Publicado: (2016)

Fasting blood glucose level and hypertension risk in aging benign prostatic hyperplasia patients
por: Zi, Hao, et al.
Publicado: (2019)

Relationships between serum Omentin-1 levels and bone mineral density in older men with osteoporosis
por: Yang, Li, et al.
Publicado: (2016)

Silodosin in the treatment of benign prostatic hyperplasia
por: Rossi, Maxime, et al.
Publicado: (2010)

Management of benign prostatic hyperplasia with silodosin
por: Yamanishi, Tomonori, et al.
Publicado: (2009)

Pathophysiology of clinical benign prostatic hyperplasia
por: Foo, Keong Tatt
Publicado: (2017)

Epidemiology of clinical benign prostatic hyperplasia
por: Lim, Kok Bin
Publicado: (2017)

Botulinum toxin and benign prostatic hyperplasia
por: Ng, Lay Guat
Publicado: (2018)

Solving the benign prostatic hyperplasia puzzle
por: Foo, Keong Tatt
Publicado: (2016)

Tissue microenvironment and benign prostatic hyperplasia
por: Wei, Xing, et al.
Publicado: (2019)

Different levels of serum microRNAs in prostate cancer and benign prostatic hyperplasia: evaluation of potential diagnostic and prognostic role
por: Cochetti, Giovanni, et al.
Publicado: (2016)

Genome-wide associations for benign prostatic hyperplasia reveal a genetic correlation with serum levels of PSA
por: Gudmundsson, Julius, et al.
Publicado: (2018)

Decreased Levels of Serum Omentin-1 in Patients with Inflammatory Bowel Disease
por: Yin, Jian, et al.
Publicado: (2015)

Clinical significance of serum omentin-1 levels in patients with pancreatic adenocarcinoma
por: Karabulut, Senem, et al.
Publicado: (2016)

A multicenter retrospective study of transurethral prostate split for benign prostate hyperplasia
por: Wei, Jingchao, et al.
Publicado: (2022)

Serum prostate specific antigen is a good indicator of prostatic volume in men with benign prostatic hyperplasia
por: Abotsi, Ebenezer, et al.
Publicado: (2022)

Serum testosterone and prostate-specific antigen levels are major risk factors for prostatic volume increase among benign prostatic hyperplasia patients
por: Kusuma Duarsa, Gede Wirya, et al.
Publicado: (2021)

Prostatitis and benign prostatic hyperplasia: emerging infectious diseases?
por: Hennenfent, B
Publicado: (1997)

Zinc status in benign prostatic hyperplasia and prostate carcinoma
por: Wiwanitkit, Somsri, et al.
Publicado: (2012)

Laparoscopic simple prostatectomy with prostatic urethra preservation for benign prostatic hyperplasia
por: Xing, Nianzeng, et al.
Publicado: (2012)

Linking Pre-Diabetes with Benign Prostate Hyperplasia. IGFBP-3: A Conductor of Benign Prostate Hyperplasia Development Orchestra?
por: Protopsaltis, Ioannis, et al.
Publicado: (2013)

Correlation between Prostatitis, Benign Prostatic Hyperplasia and Prostate Cancer: A systematic review and Meta-analysis
por: Zhang, Lei, et al.
Publicado: (2020)

Bipolar transurethral enucleation of prostate versus photoselective vaporization for symptomatic benign prostatic hyperplasia (>70 ml)
por: Mu, Xiao-Nan, et al.
Publicado: (2017)

Comparison between selected hormone and protein levels in serum and prostate tissue homogenates in men with benign prostatic hyperplasia and metabolic disorders
por: Grzesiak, Katarzyna, et al.
Publicado: (2018)

The Symptoms of Benign Prostatic Hyperplasia Patients with Stromal-Dominated Hyperplasia Nodules May Be Associated with Prostate Fibrosis
por: Cao, Ying, et al.
Publicado: (2023)

Three-dimensional measurement and analysis of benign prostatic hyperplasia
por: Feng, Yankun, et al.
Publicado: (2021)

Morphological Changes of Benign Prostatic Hyperplasia in Culture
por: McMahon, M. J., et al.
Publicado: (1973)

Benign Prostatic Hyperplasia: from Bench to Clinic
por: Yoo, Tag Keun, et al.
Publicado: (2012)

VASTI THERAPY IN THE MANAGEMENT OF BENIGN PROSTATE HYPERPLASIA
por: Gupta, Shivaji, et al.
Publicado: (1997)

Cannot write session to /tmp/vufind_sessions/sess_cuve8hmpg6i6eratibbhcuo28j